Cargando…
Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy
Biological therapy, with its multifaceted applications, has revolutionized the treatment of tumors, mainly due to its ability to exclusively target cancer cells and reduce the adverse effects on normal tissues. This review focuses on the therapies targeting the CXCR4 and CD47 receptors. We surveyed...
Autores principales: | Leo, Manuela, Sabatino, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604048/ https://www.ncbi.nlm.nih.gov/pubmed/36293358 http://dx.doi.org/10.3390/ijms232012499 |
Ejemplares similares
-
CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
por: Mezzapelle, Rosanna, et al.
Publicado: (2021) -
CXCR4 Chemokine Receptor Overview: Biology, Pathology and Applications in Imaging and Therapy
por: Jacobson, Orit, et al.
Publicado: (2013) -
The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023) -
CXCR4/CXCL12 Activities in the Tumor Microenvironment and Implications for Tumor Immunotherapy
por: Mezzapelle, Rosanna, et al.
Publicado: (2022) -
Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy
por: Huang, Bo, et al.
Publicado: (2021)